Athanasios Bikas
YOU?
Author Swipe
View article: MON-380 Development of a Prognostic Cell Cycle Progression Score in Preoperative Thyroid Tumor Samples to Predict Prognosis
MON-380 Development of a Prognostic Cell Cycle Progression Score in Preoperative Thyroid Tumor Samples to Predict Prognosis Open
Disclosure: A. Bikas: None. E. Su: None. H. Patankar: None. M. Alshalalfa: Veracyte, Inc. Y. Hao: Veracyte, Inc. J.P. Klopper: Veracyte, Inc.. T. Pappa: None. Introduction: Alterations in cell cycle regulatory genes may lead to abnormal ce…
View article: MON-785 Immunogenomic Analysis Of Advanced Thyroid Cancer Reveals A Distinct Immune Devoid Profile In RAS Mutant Tumors
MON-785 Immunogenomic Analysis Of Advanced Thyroid Cancer Reveals A Distinct Immune Devoid Profile In RAS Mutant Tumors Open
T. Pappa: None. H. Patankar: None. A.N. Bikas: None. K. Sehgal: None. A.S. Alqahtani: None. J. Park: None. B. Reardon: None. S. Rodig: None. K. Pfaff: None. S. Jones: None. N. Besson: None. R. Haddad: None. E. Van Allen: None. E.K. Alexand…
View article: Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Data from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Data from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Purpose: RAS mutations occur across the spectrum of thyroid neoplasms, and more tools are needed for better prognostication. The objective of this study was to evaluate how additional genetic events affecting key genes modify prognosis in …
View article: Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier Open
Context Molecular testing can refine the risk of malignancy in thyroid nodules with indeterminate cytology to decrease unnecessary diagnostic surgery. Objective This study was performed to evaluate the outcomes of cytologically indetermina…
View article: Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules Open
Context Active surveillance for papillary thyroid cancer (PTC) meeting criteria for surgical resection is uncommon. Which patients may prove reasonable candidates for this approach is not well defined. Objective This work aimed to examine …
View article: FRI200 Severe Cushing Syndrome Due To An ACTH-producing Pheochromocytoma
FRI200 Severe Cushing Syndrome Due To An ACTH-producing Pheochromocytoma Open
Disclosure: G.A. Stamatiades: None. A. Bikas: None. H.J. Shah: None. K. Wong: None. A. Vaidya: None. M. Nehs: None. S.S. Basaria: None. Background: Pheochromocytomas are rare catecholamine-secreting tumors that arise from sympathetic adren…
View article: Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Purpose:RAS mutations occur across the spectrum of thyroid neoplasms, and more tools are needed for better prognostication. The objective of this study was to evaluate how additional genetic events affecting key genes modify prognosis in p…
View article: Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Purpose:RAS mutations occur across the spectrum of thyroid neoplasms, and more tools are needed for better prognostication. The objective of this study was to evaluate how additional genetic events affecting key genes modify prognosis in p…
View article: Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Data from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Purpose:RAS mutations occur across the spectrum of thyroid neoplasms, and more tools are needed for better prognostication. The objective of this study was to evaluate how additional genetic events affecting key genes modify prognosis in p…
View article: Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S1. List of all variants detected by Oncopanel in 78 RAS-mutant thyroid tumors
View article: Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S3. Comparison of clinical and pathologic characteristics of differentiated thyroid cancers with diploid versus heterozygous losses at chromosome 22q
View article: Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Supplementary Table S2. Characteristics of patients with RAS-mutant anaplastic thyroid cancer
View article: Additional Oncogenic Alterations in <i>RAS</i> -Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
Additional Oncogenic Alterations in <i>RAS</i> -Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes Open
Purpose: RAS mutations occur across the spectrum of thyroid neoplasms, and more tools are needed for better prognostication. The objective of this study was to evaluate how additional genetic events affecting key genes modify prognosis in …
View article: Thyroid Nodule Shape Independently Predicts Risk of Malignancy
Thyroid Nodule Shape Independently Predicts Risk of Malignancy Open
Context Predictive models of thyroid nodule cancer risk are presently based upon nodule composition, echogenicity, margins, and the presence of microcalcifications. Nodule shape has shown promise to be an additive factor helping determine …